JP2020502120A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502120A5 JP2020502120A5 JP2019531743A JP2019531743A JP2020502120A5 JP 2020502120 A5 JP2020502120 A5 JP 2020502120A5 JP 2019531743 A JP2019531743 A JP 2019531743A JP 2019531743 A JP2019531743 A JP 2019531743A JP 2020502120 A5 JP2020502120 A5 JP 2020502120A5
- Authority
- JP
- Japan
- Prior art keywords
- delivery molecule
- payload
- data
- see
- see description
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023117292A JP2023134730A (ja) | 2016-12-14 | 2023-07-19 | 核酸およびタンパク質ペイロード送達のための方法および組成物 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662434344P | 2016-12-14 | 2016-12-14 | |
| US62/434,344 | 2016-12-14 | ||
| US201762443522P | 2017-01-06 | 2017-01-06 | |
| US201762443567P | 2017-01-06 | 2017-01-06 | |
| US62/443,522 | 2017-01-06 | ||
| US62/443,567 | 2017-01-06 | ||
| US201762517346P | 2017-06-09 | 2017-06-09 | |
| US62/517,346 | 2017-06-09 | ||
| PCT/US2017/066541 WO2018112278A1 (en) | 2016-12-14 | 2017-12-14 | Methods and compositions for nucleic acid and protein payload delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023117292A Division JP2023134730A (ja) | 2016-12-14 | 2023-07-19 | 核酸およびタンパク質ペイロード送達のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502120A JP2020502120A (ja) | 2020-01-23 |
| JP2020502120A5 true JP2020502120A5 (https=) | 2021-08-12 |
| JP7317706B2 JP7317706B2 (ja) | 2023-07-31 |
Family
ID=62488586
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531743A Active JP7317706B2 (ja) | 2016-12-14 | 2017-12-14 | 核酸およびタンパク質ペイロード送達のための方法および組成物 |
| JP2019531758A Pending JP2020502124A (ja) | 2016-12-14 | 2017-12-14 | 核酸および／またはタンパク質ペイロード送達のための組成物および方法 |
| JP2023031534A Pending JP2023071853A (ja) | 2016-12-14 | 2023-03-02 | 核酸および／またはタンパク質ペイロード送達のための組成物および方法 |
| JP2023117292A Pending JP2023134730A (ja) | 2016-12-14 | 2023-07-19 | 核酸およびタンパク質ペイロード送達のための方法および組成物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531758A Pending JP2020502124A (ja) | 2016-12-14 | 2017-12-14 | 核酸および／またはタンパク質ペイロード送達のための組成物および方法 |
| JP2023031534A Pending JP2023071853A (ja) | 2016-12-14 | 2023-03-02 | 核酸および／またはタンパク質ペイロード送達のための組成物および方法 |
| JP2023117292A Pending JP2023134730A (ja) | 2016-12-14 | 2023-07-19 | 核酸およびタンパク質ペイロード送達のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US10975388B2 (https=) |
| EP (2) | EP3554546A4 (https=) |
| JP (4) | JP7317706B2 (https=) |
| KR (4) | KR20240172763A (https=) |
| CN (2) | CN110582302A (https=) |
| AU (2) | AU2017378427A1 (https=) |
| CA (2) | CA3045134A1 (https=) |
| IL (2) | IL267034B2 (https=) |
| RU (2) | RU2019121801A (https=) |
| WO (2) | WO2018112282A1 (https=) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210069016A1 (en) * | 2008-11-13 | 2021-03-11 | Gholam A. Peyman | Neurodegenerative Disorder Treatment Method |
| RU2019126483A (ru) | 2017-01-23 | 2021-02-24 | Ридженерон Фармасьютикалз, Инк. | Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение |
| KR20190139869A (ko) | 2017-04-11 | 2019-12-18 | 리제너론 파마슈티칼스 인코포레이티드 | 하이드록시스테로이드 (17-베타) 탈수소효소(hsd17b) 패밀리의 구성원의 조절인자의 활성도를 스크리닝하기 위한 검정 |
| WO2018232356A1 (en) | 2017-06-15 | 2018-12-20 | The Regents Of The University Of California | Targeted non-viral dna insertions |
| KR20200033259A (ko) | 2017-07-31 | 2020-03-27 | 리제너론 파마슈티칼스 인코포레이티드 | 생체내에서 CRISPR/Cas-매개된 파괴 또는 삭제 및 외인성 도너 핵산과의 CRISPR/Cas-유도된 재조합을 평가하기 위한 방법 및 조성물 |
| CN110891420B (zh) | 2017-07-31 | 2022-06-03 | 瑞泽恩制药公司 | Cas转基因小鼠胚胎干细胞和小鼠及其应用 |
| AU2018348195B2 (en) | 2017-10-11 | 2025-05-15 | Regeneron Pharmaceuticals, Inc. | Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation |
| JP7101419B2 (ja) | 2017-10-27 | 2022-07-15 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 内因性ｔ細胞受容体の標的置換 |
| EP3592140A1 (en) | 2018-03-19 | 2020-01-15 | Regeneron Pharmaceuticals, Inc. | Transcription modulation in animals using crispr/cas systems |
| AU2019239971B2 (en) | 2018-03-21 | 2025-09-11 | Regeneron Pharmaceuticals, Inc. | 17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof |
| KR20210039983A (ko) * | 2018-04-24 | 2021-04-12 | 리간달 인코포레이티드 | 게놈 편집을 위한 방법 및 조성물 |
| WO2020051396A1 (en) * | 2018-09-08 | 2020-03-12 | Blueallele, Llc | Methods and compositions for modifying the von willebrand factor gene |
| KR102769565B1 (ko) | 2018-09-19 | 2025-02-20 | 애로우헤드 파마슈티컬스 인코포레이티드 | 17베타-HSD 유형 13- (HSD17B13)의 발현을 억제하기 위한 RNAi 작용제, 그의 조성물, 및 사용 방법 |
| JP2022512977A (ja) | 2018-11-08 | 2022-02-07 | サメイション バイオ， インコーポレイテッド | ミニヌクレオソームコアタンパク質及び核酸送達における使用 |
| AU2019392748A1 (en) * | 2018-12-05 | 2021-06-10 | Fred Hutchinson Cancer Center | Reduced and minimal manipulation manufacturing of genetically-modified cells |
| CN113544266A (zh) * | 2018-12-17 | 2021-10-22 | 博德研究所 | Crispr相关转座酶系统和其使用方法 |
| US11249941B2 (en) * | 2018-12-21 | 2022-02-15 | Palo Alto Research Center Incorporated | Exabyte-scale data storage using sequence-controlled polymers |
| CN111363013B (zh) * | 2018-12-25 | 2021-11-19 | 深圳先进技术研究院 | 多组分纳米颗粒簇的构建方法 |
| CN109735540B (zh) * | 2019-01-22 | 2022-05-31 | 南京鼓楼医院 | SH2D1A基因、sgRNA及其应用 |
| US20210379192A1 (en) * | 2019-01-25 | 2021-12-09 | Mantra Bio, Inc. | Skeletal muscle targeting moieties and uses thereof |
| AU2020232238B2 (en) | 2019-03-01 | 2025-10-30 | Flagship Pioneering Innovations Vi, Llc | Polyribonucleotides and cosmetic uses thereof |
| MA55082A (fr) | 2019-03-01 | 2022-01-05 | Flagship Pioneering Innovations Vi Llc | Compositions, procédés, et kits pour l'administration de polyribonucléotides |
| CA3138991A1 (en) * | 2019-05-02 | 2020-11-05 | Ligandal, Inc. | Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents |
| WO2020261227A1 (en) | 2019-06-26 | 2020-12-30 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
| JP7630904B2 (ja) * | 2019-07-23 | 2025-02-18 | 株式会社東芝 | 核酸導入キャリア、核酸導入キャリアセット、核酸導入組成物及び核酸導入方法 |
| CN110628723B (zh) * | 2019-09-05 | 2021-05-04 | 清华大学 | 基因修饰MSCs治疗2型糖尿病 |
| US20210163935A1 (en) * | 2019-09-05 | 2021-06-03 | Trevor P. Castor | Targeted Critical Fluid Nanoparticles Platform for Delivery of Nucleic Acids for Treatment of HIV-1 and Other Diseases |
| US12521451B2 (en) | 2019-11-08 | 2026-01-13 | Regeneron Pharmaceuticals, Inc. | CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy |
| CN112779317A (zh) * | 2019-11-11 | 2021-05-11 | 香港中文大学深圳研究院 | 一种用于小分子核糖核酸检测的试剂及其应用 |
| WO2021097305A1 (en) * | 2019-11-15 | 2021-05-20 | The Regents Of The University Of California | Supramolecular nanosubstrate-mediated delivery system enables crispr/cas9 knockin of hemoglobin beta gene-a potential therapeutic solution for hemoglobinopathies |
| CN115698282A (zh) | 2020-01-13 | 2023-02-03 | 福路伦特生物科学公司 | 单细胞测序 |
| WO2021154888A1 (en) | 2020-01-27 | 2021-08-05 | Mantra Bio. Inc. | Non-naturally occurring vesicles comprising a chimeric vesicle localization moiety, methods of making and uses thereof |
| CA3172878A1 (en) * | 2020-02-25 | 2021-09-02 | Ligandal, Inc. | Identification of biomimetic viral peptides and uses thereof |
| WO2021168575A1 (en) * | 2020-02-27 | 2021-09-02 | Quadrumix Biotechnology Inc. | Polypeptides directed against viral infection and uses thereof |
| US11866782B2 (en) | 2020-03-16 | 2024-01-09 | Fluent Biosciences Inc. | Multi-omic analysis in monodisperse droplets |
| WO2021195169A1 (en) | 2020-03-24 | 2021-09-30 | Fluent Biosciences Inc. | Viral detection using template emulsification |
| AU2021254697A1 (en) | 2020-04-13 | 2022-11-10 | Summation Bio Inc. | Modified mini-nucleosome core proteins and use in nucleic acid delivery |
| EP4153223A1 (en) | 2020-05-20 | 2023-03-29 | Flagship Pioneering Innovations VI, LLC | Immunogenic compositions and uses thereof |
| EP4182477A4 (en) | 2020-07-15 | 2024-09-11 | Fluent Biosciences Inc. | MULTI-LEVEL LIGATION OLIGOS |
| CN111968707B (zh) * | 2020-08-07 | 2022-06-17 | 上海交通大学 | 基于能量的原子结构与电子密度图多目标优化拟合预测方法 |
| CN111888333A (zh) * | 2020-08-11 | 2020-11-06 | 深圳大学 | 一种转铁蛋白受体靶向的纳米胶束及其制备方法与应用 |
| WO2022040605A1 (en) * | 2020-08-21 | 2022-02-24 | Ligandal, Inc. | Compositions and methods for nanoparticle seed substrates |
| AU2021336976A1 (en) | 2020-09-03 | 2023-03-23 | Flagship Pioneering Innovations Vi, Llc | Immunogenic compositions and uses thereof |
| JP2024503303A (ja) * | 2020-12-30 | 2024-01-25 | バイオーケストラ カンパニー， リミテッド | ミセルナノ粒子及びその使用 |
| WO2022144811A1 (en) * | 2020-12-30 | 2022-07-07 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
| CA3218849A1 (en) * | 2021-05-14 | 2022-11-17 | University Of Rochester | Variants of sirt6 for use in preventing and/or treating age-related diseases |
| CA3220477A1 (en) * | 2021-05-18 | 2022-11-24 | Fluent Biosciences Inc. | Perturbed genomic expression in pretemplated instant partitions |
| US20230076395A1 (en) * | 2021-08-17 | 2023-03-09 | California Institute Of Technology | Cell-to-cell delivery of rna circuits |
| KR102775653B1 (ko) * | 2021-09-15 | 2025-03-05 | 한국기초과학지원연구원 | 아르기닌 리치 펩타이드를 포함하는 단백질 분해제 및 이를 이용한 단백질 이상질환의 예방 또는 치료용 약학적 조성물 |
| JP2024537991A (ja) | 2021-10-14 | 2024-10-18 | アーセナル バイオサイエンシズ インコーポレイテッド | 共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞 |
| KR20240117571A (ko) | 2021-12-08 | 2024-08-01 | 리제너론 파마슈티칼스 인코포레이티드 | 돌연변이 마이오실린 질환 모델 및 이의 용도 |
| CN115304756B (zh) * | 2022-01-30 | 2023-05-09 | 上海科技大学 | 一种五元脂质纳米颗粒及其制备方法和应用 |
| CN114480672B (zh) * | 2022-02-22 | 2023-08-15 | 青岛农业大学 | 一种通过miR-145筛选高产肉率碱地黑牛的方法 |
| CN114933658B (zh) * | 2022-04-24 | 2023-07-11 | 深圳市鹏泰生物科技有限公司 | 一种短肽元件及其应用方法 |
| CN115184480B (zh) * | 2022-05-24 | 2024-07-09 | 南京中医药大学 | 一种用于鉴定华蟾素制剂或蟾皮的特征多肽及其含量测定方法与应用 |
| CN115177734B (zh) * | 2022-07-05 | 2025-03-14 | 中国人民解放军空军军医大学 | 一种靶向干预线粒体基因表达的工程化外泌体及其构建方法和应用 |
| CN115350330B (zh) * | 2022-09-01 | 2023-10-20 | 北京化工大学 | 一种负电性小分子调控的表面在蛋白差异性黏附上的应用 |
| US12534721B2 (en) | 2022-10-06 | 2026-01-27 | Illumina, Inc. | Quantitative detection and analysis of moleculesip |
| WO2024098238A1 (en) * | 2022-11-08 | 2024-05-16 | Pulsar Therapeutics Inc. | Methods for treating hemoglobinopathies |
| WO2025049677A1 (en) * | 2023-08-31 | 2025-03-06 | Tufts Medical Center, Inc. | Use of nanoparticles in therapeutic and imaging methods |
| AU2024367190A1 (en) * | 2023-10-23 | 2026-04-23 | The Board Of Regents Of The University Of Texas System | Novel endoplasmic reticulum targeting signal peptides and uses thereof |
| CN117599200A (zh) * | 2023-10-27 | 2024-02-27 | 华中科技大学 | 一种新型的双链rna递送载体及应用 |
| WO2025102075A1 (en) * | 2023-11-09 | 2025-05-15 | The Board Of Regents Of The University Of Texas System | Endogenous synapse targeting signal peptides and uses thereof |
| WO2025207378A1 (en) * | 2024-03-25 | 2025-10-02 | Massachusetts Institute Of Technology | Scalable and high throughput assembly of layer-by-layer nanoparticles |
| KR20250160320A (ko) * | 2024-05-03 | 2025-11-12 | 한양대학교 산학협력단 | 엔도좀 탈출 효율이 향상된 항 인간 트랜스페린 수용체 항체, 및 이를 이용한 다중특이적 항체 및 약학 조성물 |
Family Cites Families (111)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| US6051429A (en) | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
| US6379966B2 (en) | 1999-02-26 | 2002-04-30 | Mirus Corporation | Intravascular delivery of non-viral nucleic acid |
| EP1035158A4 (en) | 1997-10-29 | 2002-01-30 | Kanebo Ltd | RESIN COUPLING WITH BIODEGRADABILITY AND FOAMABILITY |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6794136B1 (en) | 2000-11-20 | 2004-09-21 | Sangamo Biosciences, Inc. | Iterative optimization in the design of binding proteins |
| CA2372214A1 (en) | 1999-04-30 | 2000-11-09 | Amylin Pharmaceuticals, Inc. | Modified exendins and exendin agonists |
| US7098032B2 (en) | 2001-01-02 | 2006-08-29 | Mirus Bio Corporation | Compositions and methods for drug delivery using pH sensitive molecules |
| AU2001257331A1 (en) | 2000-04-28 | 2001-11-12 | Sangamo Biosciences, Inc. | Methods for designing exogenous regulatory molecules |
| US7355019B2 (en) | 2000-06-06 | 2008-04-08 | Sibtech, Inc. | Cysteine-containing peptide tag for site-specific conjugation of proteins |
| US20030082561A1 (en) | 2000-07-21 | 2003-05-01 | Takashi Sera | Zinc finger domain recognition code and uses thereof |
| ES2260291T3 (es) | 2000-09-28 | 2006-11-01 | Chiron Corporation | Microparticulas para la administracion de acidos nucleicos heterologos. |
| IL155812A0 (en) | 2000-12-07 | 2003-12-23 | Lilly Co Eli | Glp-1 fusion proteins |
| WO2002057293A2 (en) | 2001-01-22 | 2002-07-25 | Sangamo Biosciences, Inc. | Modified zinc finger binding proteins |
| GB0108491D0 (en) | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
| US20040102606A1 (en) | 2001-04-24 | 2004-05-27 | Danuta Balicki | Histone H2A -derived peptides useful in gene delivery |
| US6805904B2 (en) | 2002-02-20 | 2004-10-19 | International Business Machines Corporation | Process of forming a multilayer nanoparticle-containing thin film self-assembly |
| WO2003080809A2 (en) | 2002-03-21 | 2003-10-02 | Sangamo Biosciences, Inc. | Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
| EP1499895B1 (en) | 2002-04-22 | 2008-05-07 | University Of Florida | Functionalized nanoparticles and methods of use |
| EP1519714B1 (en) | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
| WO2004085998A2 (en) | 2003-03-28 | 2004-10-07 | The Children's Hospital Of Philadelphia | Biomimetic hierarchies using functionalized nanoparticles as building blocks |
| AU2004263865B2 (en) | 2003-08-08 | 2007-05-17 | Sangamo Therapeutics, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| JP2007502833A (ja) | 2003-08-21 | 2007-02-15 | サウスウエスト・リサーチ・インスティチュート | 骨格に標的とされるナノ粒子 |
| EP1748796A4 (en) | 2004-03-05 | 2008-08-27 | Univ Texas | MULTILAYER NANOMEDICINE DELIVERY SYSTEM AND METHOD |
| MXPA06012722A (es) | 2004-05-05 | 2007-02-14 | Atugen Ag | Lipidos, complejos de lipido y su uso. |
| WO2005123142A1 (en) | 2004-06-10 | 2005-12-29 | Abraxis Bioscience, Inc. | A method using inorganic nanoparticles as non-viral vectors for gene therapy |
| US20060088599A1 (en) | 2004-08-02 | 2006-04-27 | Prasad Paras N | Amino functionalized ORMOSIL nanoparticles as delivery vehicles |
| US20090220587A1 (en) | 2005-02-01 | 2009-09-03 | United State Army | Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
| WO2007109354A2 (en) | 2006-03-21 | 2007-09-27 | Amylin Pharmaceuticals, Inc. | Peptide-peptidase inhibitor conjugates and methods of using same |
| DK2019683T4 (da) | 2006-04-25 | 2022-08-29 | Univ California | Indgivelse af vækstfaktorer til behandling af CNS-lidelser |
| US7928186B2 (en) * | 2006-08-02 | 2011-04-19 | Phoenix Pharmaceuticals, Inc. | Cell permeable bioactive peptide conjugates |
| BRPI0716427A2 (pt) | 2006-08-11 | 2014-03-11 | Dow Agrosciences Llc | Recombinação homóloga mediada por nuclease de apêndice de zinco |
| CA2689042A1 (en) | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| US20100196492A1 (en) | 2007-03-08 | 2010-08-05 | Green Jordan J | Electrostatic coating of particles for drug delivery |
| TWI428135B (zh) | 2007-03-26 | 2014-03-01 | Hirofumi Takeuchi | And a carrier composition for quick-acting nucleic acid delivery |
| AU2008305590A1 (en) | 2007-09-27 | 2009-04-02 | Sangamo Therapeutics, Inc. | Genomic editing in zebrafish using zinc finger nucleases |
| EP2205752B1 (en) | 2007-10-25 | 2016-08-10 | Sangamo BioSciences, Inc. | Methods and compositions for targeted integration |
| EP2222283A2 (en) | 2007-10-29 | 2010-09-01 | University of Massachusetts | Yeast cell wall protein (ycwp) encapsulated multilayered nanoparticles for nucleic acid delivery (sirna) |
| US20090155289A1 (en) | 2007-11-01 | 2009-06-18 | Steve Roberts | Furin-cleavable peptide linkers for drug-ligand conjugates |
| US8323618B2 (en) | 2007-11-07 | 2012-12-04 | University Of Houston System | Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof |
| AU2008325122A1 (en) | 2007-11-09 | 2009-05-14 | Northeastern University | Self-assembling micelle-like nanoparticles for systemic gene delivery |
| GB0725321D0 (en) | 2007-12-31 | 2008-02-06 | Syntaxin Ltd | Delivery vehicles |
| US7999025B2 (en) | 2008-01-28 | 2011-08-16 | University Of Utah Research Foundation | Asymmetrically-functionalized nanoparticles organized on one-dimensional chains |
| US8344116B2 (en) * | 2008-03-17 | 2013-01-01 | Case Western Reserve University | Polymers and complexes for delivery of nucleic acids to intracellular targets |
| US8324333B2 (en) | 2008-06-05 | 2012-12-04 | Wisconsin Alumni Research Foundation | Anionic charge-dynamic polymers for release of cationic agents |
| US8404636B2 (en) | 2008-07-17 | 2013-03-26 | George Mason Intellectual Properties, Inc. | Targeted delivery of antimicrobial agents |
| CA2739608A1 (en) * | 2008-10-07 | 2010-04-15 | The Regents Of The University Of California | Recombinant nell protein production |
| CN111808084A (zh) | 2008-11-10 | 2020-10-23 | 阿布特斯生物制药公司 | 用于递送治疗剂的新型脂质和组合物 |
| EP2352369B1 (en) | 2008-12-04 | 2017-04-26 | Sangamo BioSciences, Inc. | Genome editing in rats using zinc-finger nucleases |
| TWI576432B (zh) | 2009-04-07 | 2017-04-01 | 陶氏農業科學公司 | 序列特異性核酸酶之奈米粒子媒介式遞送技術 |
| RU2012103240A (ru) | 2009-07-02 | 2013-08-10 | Ангиокем Инк. | Мультимерные пептидные конъюгаты и их применение |
| US20110077581A1 (en) | 2009-09-25 | 2011-03-31 | Georgia Tech Research Corporation | Targeted cellular delivery of nanoparticles |
| CN104147611A (zh) | 2009-09-30 | 2014-11-19 | 葛兰素集团有限公司 | 具有延长的半衰期的药物融合体和缀合物 |
| AU2010305284A1 (en) | 2009-10-06 | 2012-05-03 | Angiochem Inc. | Compositions and methods for the transport of therapeutic agents |
| WO2011072246A2 (en) | 2009-12-10 | 2011-06-16 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| JPWO2011096408A1 (ja) | 2010-02-02 | 2013-06-10 | 国立大学法人 東京大学 | 複合体微粒子およびその製造方法、ならびに該複合体微粒子を用いた薬学組成物 |
| KR101198715B1 (ko) | 2010-05-14 | 2012-11-13 | 한국생명공학연구원 | 핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법 |
| WO2012012352A2 (en) * | 2010-07-19 | 2012-01-26 | Amidebio, Llc | Modified peptides and proteins |
| US9233163B2 (en) | 2010-12-28 | 2016-01-12 | The Children's Hospital Of Philadelphia | Hydrolytically releasable prodrugs for sustained release nanoparticle formulations |
| US9074187B2 (en) | 2011-03-21 | 2015-07-07 | Board Of Trustees Of The University Of Arkansas | Nanostructural materials that increase mineralization in bone cells and affect gene expression through miRNA regulation and applications of same |
| AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| CA3111953C (en) | 2011-04-05 | 2023-10-24 | Cellectis | Method for the generation of compact tale-nucleases and uses thereof |
| AU2012249390B2 (en) | 2011-04-27 | 2017-03-30 | Amyris, Inc. | Methods for genomic modification |
| US8916696B2 (en) | 2011-06-12 | 2014-12-23 | City Of Hope | Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use |
| WO2013058812A1 (en) | 2011-10-19 | 2013-04-25 | President And Fellows Of Harvard College | Targeted delivery to pancreatic islet endothelial cells |
| US8450107B1 (en) | 2011-11-30 | 2013-05-28 | The Broad Institute Inc. | Nucleotide-specific recognition sequences for designer TAL effectors |
| CZ201220A3 (cs) | 2012-01-13 | 2013-07-17 | Ústav organické chemie a biochemie Akademie ved CR, v.v.i. | Lipopolyaminy sperminového typu pro konstrukci liposomálních transfekcních systému |
| EP2841056A4 (en) | 2012-04-23 | 2015-09-16 | Massachusetts Inst Technology | STABLE LAYER COATED PARTICLES |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| HRP20181855T1 (hr) | 2012-06-08 | 2018-12-28 | Nitto Denko Corporation | Lipidi za formulacije namijenjene unosu terapijskog sredstva |
| US9993439B2 (en) | 2012-06-20 | 2018-06-12 | University Of Waterloo | Mucoadhesive nanoparticle delivery system |
| WO2014093655A2 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| IL239344B2 (en) | 2012-12-12 | 2024-06-01 | Broad Inst Inc | Systems engineering, methods and optimal guiding components for sequence manipulation |
| CN113355357B (zh) | 2012-12-12 | 2024-12-03 | 布罗德研究所有限公司 | 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化 |
| EP2840140B2 (en) | 2012-12-12 | 2023-02-22 | The Broad Institute, Inc. | Crispr-Cas based method for mutation of prokaryotic cells |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| US20140186843A1 (en) | 2012-12-12 | 2014-07-03 | Massachusetts Institute Of Technology | Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| EP3031921B1 (en) | 2012-12-12 | 2025-03-12 | The Broad Institute, Inc. | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| EP2931899A1 (en) | 2012-12-12 | 2015-10-21 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
| CN105074061B (zh) | 2012-12-13 | 2021-03-09 | 美国陶氏益农公司 | 位点特异性核酸酶活性的dna检测方法 |
| DK2931891T3 (da) | 2012-12-17 | 2019-08-19 | Harvard College | Rna-styret modificering af menneskelige genomer |
| US10227610B2 (en) | 2013-02-25 | 2019-03-12 | Sangamo Therapeutics, Inc. | Methods and compositions for enhancing nuclease-mediated gene disruption |
| US9504747B2 (en) | 2013-03-08 | 2016-11-29 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| JP6456853B2 (ja) * | 2013-03-13 | 2019-01-23 | ビオクリネ エービー | 糖尿病を治療および／または発症を制限するための方法 |
| RU2662932C2 (ru) | 2013-03-14 | 2018-07-31 | Карибо Биосайенсиз, Инк. | Композиции и способы с участием нуклеиновых кислот, нацеленных на нуклеиновые кислоты |
| CN112301024A (zh) | 2013-03-15 | 2021-02-02 | 通用医疗公司 | 使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性 |
| US9234213B2 (en) | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
| WO2014144155A1 (en) | 2013-03-15 | 2014-09-18 | Regents Of The University Of Minnesota | Engineering plant genomes using crispr/cas systems |
| US11332719B2 (en) | 2013-03-15 | 2022-05-17 | The Broad Institute, Inc. | Recombinant virus and preparations thereof |
| US20140364333A1 (en) | 2013-03-15 | 2014-12-11 | President And Fellows Of Harvard College | Methods for Live Imaging of Cells |
| US20140273230A1 (en) | 2013-03-15 | 2014-09-18 | Sigma-Aldrich Co., Llc | Crispr-based genome modification and regulation |
| US10760064B2 (en) | 2013-03-15 | 2020-09-01 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| US20140349400A1 (en) | 2013-03-15 | 2014-11-27 | Massachusetts Institute Of Technology | Programmable Modification of DNA |
| CN105263312A (zh) | 2013-04-05 | 2016-01-20 | 美国陶氏益农公司 | 用于在植物基因组内整合外源序列的方法和组合物 |
| DK3456831T3 (da) | 2013-04-16 | 2021-09-06 | Regeneron Pharma | Målrettet modifikation af rottegenom |
| EP2994531B1 (en) | 2013-05-10 | 2018-03-28 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| CA2913234A1 (en) | 2013-05-22 | 2014-11-27 | Northwestern University | Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis |
| US9873907B2 (en) | 2013-05-29 | 2018-01-23 | Agilent Technologies, Inc. | Method for fragmenting genomic DNA using CAS9 |
| US9267135B2 (en) | 2013-06-04 | 2016-02-23 | President And Fellows Of Harvard College | RNA-guided transcriptional regulation |
| EP3049116B1 (en) | 2013-09-23 | 2019-01-02 | Rensselaer Polytechnic Institute | Nanoparticle-mediated gene delivery, genomic editing and ligand-targeted modification in various cell populations |
| WO2015048577A2 (en) | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
| CA2926797A1 (en) | 2013-10-14 | 2015-04-23 | Nanosphere Health Sciences, Llc | Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP3470089A1 (en) | 2013-12-12 | 2019-04-17 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components |
| CN107073028A (zh) | 2013-12-13 | 2017-08-18 | 南洋理工大学 | 多层纳米颗粒及其制作方法和使用方法 |
| US10588972B2 (en) * | 2014-06-02 | 2020-03-17 | Li-Cor, Inc. | Phthalocyanine probes and uses thereof |
| JP6637988B2 (ja) | 2014-11-18 | 2020-01-29 | アークトゥルス セラピューティクス， インコーポレイテッド | Ｒｎａ送達のためのイオン化可能カチオン性脂質 |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
-
2017
- 2017-12-14 AU AU2017378427A patent/AU2017378427A1/en not_active Abandoned
- 2017-12-14 KR KR1020247039185A patent/KR20240172763A/ko active Pending
- 2017-12-14 EP EP17882004.9A patent/EP3554546A4/en not_active Withdrawn
- 2017-12-14 IL IL267034A patent/IL267034B2/en unknown
- 2017-12-14 CN CN201780084854.4A patent/CN110582302A/zh active Pending
- 2017-12-14 JP JP2019531743A patent/JP7317706B2/ja active Active
- 2017-12-14 US US15/842,820 patent/US10975388B2/en active Active
- 2017-12-14 RU RU2019121801A patent/RU2019121801A/ru unknown
- 2017-12-14 IL IL267033A patent/IL267033B2/en unknown
- 2017-12-14 CN CN201780085854.6A patent/CN110582301A/zh active Pending
- 2017-12-14 JP JP2019531758A patent/JP2020502124A/ja active Pending
- 2017-12-14 CA CA3045134A patent/CA3045134A1/en active Pending
- 2017-12-14 WO PCT/US2017/066545 patent/WO2018112282A1/en not_active Ceased
- 2017-12-14 KR KR1020197020171A patent/KR102641844B1/ko active Active
- 2017-12-14 WO PCT/US2017/066541 patent/WO2018112278A1/en not_active Ceased
- 2017-12-14 US US15/842,829 patent/US20180179553A1/en not_active Abandoned
- 2017-12-14 CA CA3045131A patent/CA3045131A1/en not_active Abandoned
- 2017-12-14 RU RU2019121992A patent/RU2019121992A/ru unknown
- 2017-12-14 AU AU2017378431A patent/AU2017378431A1/en not_active Abandoned
- 2017-12-14 KR KR1020247006016A patent/KR20240027888A/ko active Pending
- 2017-12-14 EP EP17881690.6A patent/EP3554555A4/en active Pending
- 2017-12-14 KR KR1020197020175A patent/KR20210035022A/ko not_active Ceased
-
2019
- 2019-12-02 US US16/701,014 patent/US20200095605A1/en active Pending
-
2020
- 2020-11-25 US US17/104,552 patent/US12123012B2/en active Active
-
2023
- 2023-03-02 JP JP2023031534A patent/JP2023071853A/ja active Pending
- 2023-07-19 JP JP2023117292A patent/JP2023134730A/ja active Pending
- 2023-08-29 US US18/458,076 patent/US20240026375A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502120A5 (https=) | ||
| JP2020502124A5 (https=) | ||
| JP7317706B2 (ja) | 核酸およびタンパク質ペイロード送達のための方法および組成物 | |
| EP3049116B1 (en) | Nanoparticle-mediated gene delivery, genomic editing and ligand-targeted modification in various cell populations | |
| JP2023071853A5 (https=) | ||
| CA2316280A1 (en) | Novel g protein-coupled receptor | |
| JP2010536341A5 (https=) | ||
| CN109529046B (zh) | 一种靶向线粒体的自组装蛋白质纳米颗粒的制备与应用 | |
| JP2014526881A5 (https=) | ||
| Kadkhodayan et al. | Generation of GFP native protein for detection of its intracellular uptake by cell-penetrating peptides | |
| CN121443325A (zh) | 激动剂胞外囊泡 | |
| CN111647042A (zh) | 骨重建调节多肽及应用 | |
| CN105999227B (zh) | FOXM1蛋白氮端（1-234 aa）的表达及其用途 | |
| KR101064914B1 (ko) | 자가면역질환, 알러지성 질환 및 염증성 질환 치료용 약제 조성물 및 이의 전달 방법 | |
| KR102208919B1 (ko) | 융합 펩타이드 나노 어셈블리와 칼슘 이온을 이용한 핵산 세포 형질도입법과 그의 응용 | |
| Haerd et al. | Structure and function of the DNA-binding domain of the glucocorticoid receptor and other members of the nuclear receptor supergene family | |
| EP0891551A1 (en) | Protein phosphatase-1 catalytic subunit interactions | |
| CN103965295B (zh) | BLyS拮抗肽、含TA-Fc融合蛋白基因的质粒及TA-Fc融合蛋白 | |
| KR20240000561A (ko) | Alpha6beta4 니코틴성 아세틸콜린 수용체에 대한 발현 시스템 및 이의 사용 방법 | |
| WO1997013522A1 (en) | Generating d-peptides: methods and compositions | |
| JP5673596B2 (ja) | 細胞膜透過性を有する製剤及び細胞膜透過性組成物 | |
| CN114316065B (zh) | 小分子肽及其应用、细胞培养基、核酸分子 | |
| EP3582761A1 (en) | Methods and compositions for vault nanoparticle immobilization of therapeutic molecules and for vault targeting | |
| Krzyzaniak et al. | Specific induction of Z-DNA conformation by a nuclear localization signal peptide of lupin glutaminyl tRNA synthetase | |
| JP2010520761A5 (https=) |